. 2016 Apr 18;15:79. doi: 10.1186/s12944-016-0247-y

Table 5.

Association of ICAM-1 polymorphism with carotid atherosclerosis progression in patients with T2DM due to statin treatment

	Statin treatment	KK genotype	KE genotype	EE genotype	p
Annual CIMT increment (μm/year)	+	11.77 (6.24–16.19)	18.06 (14.45–23.08)	22.62 (17.81–29.48)	0.13
Annual CIMT increment (μm/year)	-	14.27 (10.22–19.32)	21.28 (15.21–28.27)	28.04 (24.32–32.56)	0.04
Δ sum of the plaques thickness (mm)	+	3.76 (2.8–5.40)	4.69 (3.68–5.12)	5.86 (4.16–7.68)	0.30
Δ sum of the plaques thickness (mm)	-	4.92 (3.76–6.48)	6.40 (4.66–8.02)	6.93 (4.76–8.31)	0.74
Δ number of plaque segments	+	1.0 (0.5–2.0)	1.5 (1.0–3.0)	2.0 (1.0–3.0)	0.23
Δ number of plaque segments	-	1.0 (0.5–2.0)	2.0 (1.0–3.0)	3.0 (0.5–3.0)	0.57